Riskpilot← Back to searchSign inGet full accessOSLO ØYELEGESENTER AS
ASActiveOrg 940096464Sørkedalsveien 10A, 0369 OsloMedical specialists activities · NACE 8622Est. 198613 employees
Revenue 2024
NOK 20,9M
+10% vs 2023
EBITDA margin
5.2%
+807% vs 2023
Equity ratio
60.7%
Financial strength
Net profit 2024
NOK 237K
+127% vs 2023
| Revenue | NOK 20,9M | +10% |
| EBITDA | NOK 1,1M | +807% |
| Net profit | NOK 237K | +127% |
| Total assets | NOK 4,8M | +5% |
| Equity | NOK 2,9M | +9% |
| Employees | 13 | — |
Legal name
OSLO ØYELEGESENTER AS
Org number
940096464
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
11. mars 1986
Share capital
NOK 119 700
Employees
13 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
To styremedlemmer i fellesskap eller styrets leder og ett styremedlem i fellesskap.
Address
Sørkedalsveien 10A, 0369 Oslo
Phone
+4722931260
Email
post@oyelege.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 17 447 | 18 529 | 19 548 | 19 095 | 20 944 |
| Staff expenses | −7 698 | −7 278 | −8 101 | −8 545 | −9 395 |
| EBITDA | 706 | 2 304 | 956 | −155 | 1 098 |
| Depreciation & amort. | −967 | −1 122 | −766 | −744 | −878 |
| EBIT | −261 | 1 182 | 190 | −899 | 220 |
| Net financials | −1 | −1 | −6 | 10 | 17 |
| Profit before tax | −262 | 1 181 | 185 | −890 | 237 |
| Tax | −55 | 330 | 60 | −0 | −0 |
| Net profit | −207 | 851 | 124 | −890 | 237 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 922 | 5 451 | 5 601 | 4 604 | 4 843 |
| Equity | 2 617 | 3 468 | 3 592 | 2 703 | 2 939 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 1 305 | 1 983 | 2 009 | 1 901 | 1 904 |
| Total debt | 1 305 | 1 983 | 2 009 | 1 901 | 1 904 |
EBITDA margin
5.2%
This company
15.8%
Market median
-67% vs market
20202024
Equity ratio
60.7%
This company
38.2%
Market median
+59% vs market
20202024
Return on equity
8.1%
This company
18.4%
Market median
-56% vs market
20202024
Net profit margin
1.1%
This company
8.1%
Market median
-86% vs market
20202024
Asset turnover
4.32×
This company
1.12×
Market median
+286% vs market
20202024
Debt / equity
0.65×
This company
0.62×
Market median
+5% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Former (1) | ||
| Board of Directors | 2022 – 2023 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 14.29% | 14.29% | 2024 | |
| Individual | 14.29% | 14.29% | 2024 | |
| Individual | 14.29% | 14.29% | 2024 | |
| Individual | 14.29% | 14.29% | 2024 | |
| Individual | 14.29% | 14.29% | 2024 | |
| Individual | 14.29% | 14.29% | 2024 | |
| Individual | 8.52% | 8.52% | 2024 | |
| Individual | 5.76% | 5.76% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of OSLO ØYELEGESENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Erik Wahlstrøm | Board of Directors | 0 companies |